Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Congenital Hemophilia A

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
Baxter Healthcare Corporation
ClinicalTrials.gov Identifier:
NCT01434511
First received: September 13, 2011
Last updated: September 27, 2013
Last verified: September 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: July 2014
  Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)